Source: Annual Congress 2001 - Prognosis and strategy in lung cancer management
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vergnenègre, L. Molinier, C. Combescure, M. P. Schuller-Lebeau, C. Chouaïd, J. P. Daurès (Limoges, Toulouse, Montpellier, Paris, France). Economic evaluation of the clinical management of lung cancer in France. Eur Respir J 2001; 16: Suppl. 31, 3212

Member's Comments

No comment yet.

Related content which might interest you: Clinical management of lung cancer in France: a national survey Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001 The European initiative for quality management in lung cancer care Source: Eur Respir J 2014; 43: 1254-1277 Year: 2014 The European initiative for quality management in lung cancer care Source: International Congress 2014 – The ERJ and ERR at the forefront of respiratory medicine: 2014 guidelines Year: 2014 The European initiative for quality management in lung cancer care Source: Guideline 2014 Year: 2014 Methodology of formulation of multidiscipliary guidelines for support care management of lung cancer patients Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017 External comparison of hospitals concerning quality of oncological care of patients with lung cancer in an outcome evaluation study from a population-based regional cancer registry Source: Eur Respir J 2001; 18: Suppl. 33, 438s Year: 2001 Delays in lung cancer management Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Validation of the COPD lung cancer screening score in a community based cohort of COPD patients Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Milestones in the management of lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages? Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Quality evaluation of primary care referrals to lung cancer services and their response in South London: Clinical practice in a pragmatic setting. Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Clinical characteristics of lung cancer patients in university clinical hospital for lung diseases Sarajevo Source: Eur Respir J 2001; 18: Suppl. 33, 231s Year: 2001 Slow-growing lung cancer as an emerging entity: from screening to clinical management Source: Eur Respir J 2013; 42: 1706-1722 Year: 2013 Delay in diagnosis and management of lung cancer in developing countries Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 The approach to the surgical management of cancer in four European countries Source: Eur Respir J 2003; 22: 838-844 Year: 2003 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018 Year: 2018